We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
(-5.5%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$25.2M |
| 2 |
Ashland
ASH
|
+$17.2M |
| 3 |
IBM
IBM
|
+$17.1M |
| 4 |
Madison Square Garden
MSGS
|
+$16.7M |
| 5 |
Valero Energy
VLO
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$35.9M |
| 2 |
Qualcomm
QCOM
|
+$29M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$27.5M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
Northrop Grumman
NOC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 19.14% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Perdoceo Education
PRDO
$1.9B
| $410K | 0.01% |
42,687
-16,200
| -28% | -$158K |
|
|
NCOM
727
DELISTED
National Commerce Corporation
NCOM
| $410K | 0.01% |
10,360
+3,600
| +53% | +$137K |
|
728
Cooper Companies
COO
$13.7B
| $407K | 0.01% |
6,800
-5,200
| -43% | -$282K |
|
|
KMG
729
DELISTED
KMG Chemicals Inc
KMG
| $404K | 0.01% |
8,300
+3,000
| +57% | +$154K |
|
730
Conagra Brands
CAG
$7.07B
| $402K | 0.01% |
11,250
+2,090
| +23% | +$81K |
|
731
Cytokinetics
CYTK
$11B
| $393K | 0.01% |
+32,464
| New | +$451K |
|
|
KDMN
732
DELISTED
Kadmon Holdings, Inc.
KDMN
| $392K | 0.01% |
+100,731
| New | +$285K |
|
733
Best Buy
BBY
$18B
| $386K | 0.01% |
6,730
| – | – |
|
734
Sierra Bancorp
BSRR
$548M
| $385K | 0.01% |
+15,700
| New | +$399K |
|
735
Distribution Solutions Group
DSGR
$1.6B
| $376K | 0.01% |
33,974
+6,412
| +23% | +$67.5K |
|
736
Liberty Global Class A
LBTYA
$3.28B
| $376K | 0.01% |
+11,700
| New | +$375K |
|
|
UCTT
737
Ultra Clean Holdings
UCTT
$4.16B
| $375K | 0.01% |
19,990
-60,899
| -75% | -$1.23M |
|
|
GNRT
738
DELISTED
Gener8 Maritime, Inc.
GNRT
| $369K | 0.01% |
+64,858
| New | +$347K |
|
739
First Financial Bancorp
FFBC
$3.55B
| $363K | 0.01% |
13,100
-18,200
| -58% | -$489K |
|
740
Lineage Cell Therapeutics
LCTX
$257M
| $362K | 0.01% |
+131,455
| New | +$367K |
|
|
WMAR
741
DELISTED
West Marine Inc
WMAR
| $361K | 0.01% |
28,122
+10,222
| +57% | +$103K |
|
|
TCS
742
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $359K | 0.01% |
4,041
+694
| +21% | +$49.8K |
|
|
TVPT
743
DELISTED
Travelport Worldwide Limited
TVPT
| $359K | 0.01% |
26,089
| – | – |
|
|
CMRX
744
DELISTED
Chimerix, Inc.
CMRX
| $357K | 0.01% |
65,580
+5,120
| +8% | +$26.9K |
|
745
Marchex
MCHX
$79.7M
| $354K | 0.01% |
118,929
+22,066
| +23% | +$62.4K |
|
746
DXC Technology
DXC
$1.63B
| $352K | 0.01% |
+5,301
| New | +$352K |
|
|
HTBK
747
DELISTED
Heritage Commerce
HTBK
| $351K | 0.01% |
25,500
+240
| +1% | +$3.32K |
|
|
CDMO
748
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $351K | 0.01% |
82,414
-2,329
| -3% | -$9.53K |
|
|
CALY
749
Callaway Golf Company
CALY
$3.26B
| $347K | 0.01% |
27,163
-116,778
| -81% | -$1.43M |
|
|
RSO
750
DELISTED
Resource Capital Corp.
RSO
| $346K | 0.01% |
+34,000
| New | +$327K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2017 Portfolio in Review
As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.
- Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
- Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
- Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
- Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
- Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
- Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.